Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Allan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Neurology and Therapy|December 14, 2019
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple SclerosisMichelle Allan, Lindsay Grant
BMJ Case Reports|November 12, 2014
Purple urinary bag syndromeRhys Evans, Michelle Allan, Stephen Walsh
Multiple Sclerosis and Related Disorders|February 8, 2020
To treat or not to treat study: Comparative group inclusion considerationsLisa B Grech, Michelle Allan, Ernest Butler
Systematic Reviews|March 28, 2021
Sexual dysfunction in men with multiple sclerosisLisa B Grech, Michelle Allan, Barbora de Courten
Journal of Renal Care|July 29, 2014
The renal patient support group: supporting patients with chronic kidney disease through social mediaShahid Muhammad, Michelle Allan, Filson Ali, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2021
Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regressionJoshua Mardan, Mohammad Akhtar Hussain, Michelle Allan, et al.
Neurology. Clinical Practice|May 1, 2023
Clinical Practice Guidelines for the Detection and Treatment of Depression in Multiple Sclerosis: A Systematic ReviewGeorgia E McIntosh, Edward S Liu, Michelle Allan, et al.
The Lancet. Neurology|May 30, 2020
MS-SMART study: systematic sampling bias concernsLisa B Grech, Robert Hester, Stephen Stuckey, et al.
Multiple Sclerosis and Related Disorders|September 8, 2023
Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspectiveJeannette Lechner-Scott, Susan Agland, Michelle Allan, et al.
Neurology and Therapy|March 24, 2021
Global Peginterferon Beta-1a Tolerability Management Best Practices: A Nurse-Focused Delphi ApproachSarah White, Colleen Harris, Michelle Allan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neurology and Therapy|December 14, 2019
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple SclerosisMichelle Allan, Lindsay Grant
BMJ Case Reports|November 12, 2014
Purple urinary bag syndromeRhys Evans, Michelle Allan, Stephen Walsh
Multiple Sclerosis and Related Disorders|February 8, 2020
To treat or not to treat study: Comparative group inclusion considerationsLisa B Grech, Michelle Allan, Ernest Butler
Systematic Reviews|March 28, 2021
Sexual dysfunction in men with multiple sclerosisLisa B Grech, Michelle Allan, Barbora de Courten
Journal of Renal Care|July 29, 2014
The renal patient support group: supporting patients with chronic kidney disease through social mediaShahid Muhammad, Michelle Allan, Filson Ali, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2021
Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regressionJoshua Mardan, Mohammad Akhtar Hussain, Michelle Allan, et al.
Neurology. Clinical Practice|May 1, 2023
Clinical Practice Guidelines for the Detection and Treatment of Depression in Multiple Sclerosis: A Systematic ReviewGeorgia E McIntosh, Edward S Liu, Michelle Allan, et al.
The Lancet. Neurology|May 30, 2020
MS-SMART study: systematic sampling bias concernsLisa B Grech, Robert Hester, Stephen Stuckey, et al.
Multiple Sclerosis and Related Disorders|September 8, 2023
Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspectiveJeannette Lechner-Scott, Susan Agland, Michelle Allan, et al.
Neurology and Therapy|March 24, 2021
Global Peginterferon Beta-1a Tolerability Management Best Practices: A Nurse-Focused Delphi ApproachSarah White, Colleen Harris, Michelle Allan, et al.
Pageof 2